CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-24). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 1728 · Search date 2026-07-24 · Methodology v0.6

Therapeutic ultrasound,
does it really help with Improving chronic nonspecific low back pain and disability?

30-Second Summary
D
Evidence Grade D · 28 · Safety unknown
Therapeutic ultrasound has not shown a reliable added benefit for chronic low back pain or function
What the
research shows
Therapeutic ultrasound is rated D for chronic nonspecific low back pain and disability. Ebadi 2012 randomized 50 people, analyzed all 50 by last-observation-carried-forward intention to treat, and had 48 completers; the prespecified primary FRI and pain VAS outcomes both failed. The Cochrane placebo comparison for pain included three trials and 121 participants, MD -7.12 (95% CI -17.99 to 3.75), with very low certainty. This therapeutic use differs from diagnostic or screening ultrasound.
What the
ads claim
Mechanistic claims about deep heat, blood flow, and tissue repair are presented as certain improvements in pain and daily function, although patient-important outcomes were null or small.
*

Useful facts when choosing a product

  • The key trial used 1-MHz continuous ultrasound at 1.5 W/cm2 for ten sessions over four weeks alongside exercise.
  • Diagnostic imaging, screening ultrasound, and high-intensity focused ultrasound are different technologies and uses.
  • Suspected tumor, infection, fracture, impaired sensation, and treatment near a pregnant uterus require professional contraindication screening.
Gap Measurement · Verdict 1728 · D 28
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Ebadi 2012 randomized 50 people to continuous ultrasound plus exercise or sham ultrasound plus exercise, analyzed all 50 by last-observation-carried-forward intention to treat, and had 48 completers. Primary FRI and VAS interactions failed with P=.31 and P=.48. In the 2020 Cochrane review, the placebo comparison for pain included three trials and 121 participants, MD -7.12 (95% CI -17.99 to 3.75), with very low certainty.

02

Why this is classified as D (28)

Fifty randomized participants were included in the last-observation-carried-forward analysis, and both primary FRI and pain outcomes failed. Ten-trial synthesis showed null pain and a small functional effect, giving D with 28 points.

Counterpoint. It should not replace exercise and education-based rehabilitation and, if used, should remain an adjunct with reassessment.

Rejudgment record. Cross-check applied — The trial randomized 50, analyzed all 50 by LOCF intention to treat, and had 48 completers with failed primary function and pain outcomes; the Cochrane placebo pain analysis of three trials and 121 participants was null with very low certainty

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Short-term reduction in low back pain intensityDThe key trial and placebo meta-analysis were null.
Improvement in back-specific functional disabilityDThe key FRI outcome failed and the pooled small effect was not clinically important.
Improvement in overall recovery or satisfactionDTwo studies found little to no difference with low certainty.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Ebadi S et al. 2012Single-blind randomized sham-controlled trial10Supported by the Research Deputy of Tehran University of Medical Sciences; not device-manufacturer-ledPrimary FRI function and VAS painGroup-by-time effects failed for FRI (P=.31) and VAS (P=.48).Key direct evidence
Ebadi S et al. 2020Cochrane systematic review and meta-analysis121Academic Cochrane review; no manufacturer funding reportedPain, back-specific function, and overall improvementPain versus placebo was null, MD -7.12 (95% CI -17.99 to 3.75), with very low certainty.Key synthesis
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-07-24).

Ebadi S, Nakhostin Ansari N, Naghdi S, et al. The effect of continuous ultrasound on chronic non-specific low back pain: a single blind placebo-controlled randomized trial. BMC Musculoskelet Disord. 2012;13:192. PMID: 23031570. DOI: 10.1186/1471-2474-13-192.
checked
Ebadi S, Henschke N, Forogh B, et al. Therapeutic ultrasound for chronic low back pain. Cochrane Database Syst Rev. 2020;2020(7):CD009169. PMID: 32623724. DOI: 10.1002/14651858.CD009169.pub3.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-24 · Corrections: none

Cite this verdict

Therapeutic ultrasound x chronic nonspecific low back pain and disability Evidence Grade D card
[Chamgap] Therapeutic ultrasound x chronic nonspecific low back pain and disability — Evidence Grade D·28. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/joint-bone/therapeutic-ultrasound-chronic-nonspecific-low-back-pain/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.